Pioglitazone as a novel therapeutic approach in chronic granulomatous disease

J Allergy Clin Immunol. 2016 Jun;137(6):1913-1915.e2. doi: 10.1016/j.jaci.2016.01.033. Epub 2016 Apr 4.
No abstract available

Publication types

  • Case Reports
  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Granulomatous Disease, Chronic / drug therapy*
  • Humans
  • Infant
  • Male
  • Pioglitazone
  • Thiazolidinediones / administration & dosage*

Substances

  • Thiazolidinediones
  • Pioglitazone